Status:
UNKNOWN
Molecular Analysis of Blood Samples in Standardized Cancer Care Referrals for SCAN and CUP
Lead Sponsor:
Christer Ericsson
Collaborating Sponsors:
Karolinska Institutet
iCellate Medical
Conditions:
Neoplasms, Unknown Primary
Cancer
Eligibility:
All Genders
18-125 years
Brief Summary
Patients with suspected cancer (SCAN) and cancer of unknown primary tumor (CUP) are vulnerable because the investigation is difficult and expensive and have poor prognosis because few effective establ...
Eligibility Criteria
Inclusion
- 200 patients who were referred to be investigated and diagnosed at the Diagnostic Centre (DC) in Södertälje, Sweden, for suspected cancer (SCAN) with serious non-specific symptoms with signs of cancer, or with suspected cancer of unknown primary (CUP) and which give informed consent to participate in the study.
Exclusion
- All patients who have been referred and consented are included.
Key Trial Info
Start Date :
September 30 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04025970
Start Date
September 30 2019
End Date
December 31 2021
Last Update
October 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Diagnostiskt Centrum, Södertälje Sjukhus
Södertälje, Stockholm County, Sweden, 152 86